Hemlibra

DHPC | LPI

Disclaimer - Kindly note that it takes approximately up to 6 months to implement the revised PI in commercial stocks imported into India after submission to the health authorities. All PIs notified to or approved by the CDSCO are published on this website for all the HCPs prescribing Roche drugs within 10 calendar days.

Safety Update Information for Healthcare Professionals (Haemophilia):

RMin A _HCP Guide for Hemlibra_Thrombotic microangiopathy and Thromboembolism associated with Emicizumab and aPCC dated August 2020RMin A _HCP Guide for Hemlibra_Thrombotic microangiopathy and Thromboembolism associated with Emicizumab and aPCC dated August 2020

Safety Update Information for Healthcare Professionals. I understand the following:
1. The information contained in this website page is for the sole purpose of use and knowledge of Healthcare Professionals (HCPs) only.
2. If any Individual other than HCPs access the information contained in this website page and act thereon, then Roche will not be liable for any consequences in relation thereto.
3. Patients and their relatives should not access the information contained in this website page. They are advised to consult their treating physicians.
By clicking Agree, I hereby confirm that I am a Healthcare Professional and agree to the terms and conditions mentioned above.